Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 19-11-2024 |
Asset Class: Equity |
Benchmark: BSE Healthcare TRI |
TER: 2.38% As on (28-02-2025) |
Status: Open Ended Schemes |
Minimum Investment: 5,000 |
Minimum Topup: 1,000 |
Total Assets: 96 Cr As on 28-02-2025(Source:AMFI) |
Turn over: - |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Standard Deviation | - |
Sharpe Ratio | - |
Alpha | - |
Beta | - |
Yield to Maturity | - |
Average Maturity | - |
Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
---|---|---|---|---|---|---|
PGIM India Healthcare Fund - Regular Plan - Growth Option | 19-11-2024 | - | - | - | - | - |
HDFC Pharma and Healthcare Fund - Growth Option | 04-10-2023 | 29.56 | - | - | - | - |
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth | 06-02-2024 | 27.98 | - | - | - | - |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 14-07-1999 | 20.79 | 38.64 | 22.99 | 30.42 | 11.65 |
UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | 20.07 | 37.55 | 19.78 | 28.47 | 10.7 |
Small Cap
31.83%
Others
4.69%
Large Cap
34.58%
Mid Cap
28.9%